Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Dr. Reddy’s 4Q10 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Dr. Reddy’s 4Q10

North America revenue growth was 18% for the year, with 11 new product launches.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dr. Reddy’s 4Q10

4Q Revenues: $453.0 million (+23%)

4Q Earnings: $75.0 million (+101%)

FY Revenues: $1.7 billion (+6%)

FY Earnings: $248.0 million (earnings were $24.0 million FY10)

Comments: North America revenue growth was 18% for the year, with 11 new product launches. Russia had revenue growth of 29% with volume growth and OTC initiatives. India had revenue growth of 15%, with continued growth of key brands and new products. Germany revenue was down 17% in Euro terms, but had improved profitability. Global Generics revenue was $1.2 billion for the year (+10%), led by performance in North America and Emerging Markets.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters